RILEY JENNIFER (Chief Strategy Officer) reported 1 transaction at AVALO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/12/2026ACC: 0002047607-26-000006
Officer· Chief Strategy Officer
Since Feb 2026
-588.00
Net shares
Net seller
$7.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
588.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−588.00
Price / share
$13.10
Trade value
$7.70K
% of position
1.5%
6/10/2026
40.28K→39.70K
Total
Net shares
−588.00
Net value
-$7.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | F · Tax Withholding | −588.00 | $13.10 | $7.70K | 1.5% | 40.28K | 39.70K |
| Total | −588.00 | -$7.70K | ||||||
Derivative Transactions0
No derivative transactions reported